Daniel Scavilla T.'s most recent trade in DENTSPLY Sirona Inc was a trade of 4,095 Common Stock done at an average price of $10.2 . Disclosure was reported to the exchange on May 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director, President, CEO & Member of BOD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.21 per share. | 22 May 2026 | 4,095 | 157,754 (0%) | 0% | 10.2 | 41,810 | Common Stock |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director, President, CEO & Member of BOD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2026 | 3,554 | 3,554 | - | - | Phantom Stock (Supplemental Executive Retirement Plan) SERP | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director, President, CEO & Member of BOD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 2,066,600 | 2,066,600 | - | - | Stock Option (Right to Buy) | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director, President, CEO & Member of BOD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 145,089 | 161,839 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director, President, CEO & Member of BOD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2026 | 245 | 17,944 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director, President, CEO & Member of BOD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2025 | 223 | 17,698 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director, President, CEO & Member of BOD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2025 | 1,102,600 | 1,102,600 | - | - | Stock Option (Right to Buy) | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2025 | 210 | 17,475 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 13,880 | 17,265 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Daniel T. Scavilla | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 3,385 | 3,385 (0%) | 0% | 0 | Common Stock | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 21 Nov 2024 | 130,000 | 0 (0%) | 0% | 85 | 11,050,000 | Class A Common Stock | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 21 Nov 2024 | 80,000 | 130,000 (0%) | 0% | 43.6 | 3,486,400 | Class A Common Stock | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 21 Nov 2024 | 80,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 21 Nov 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 21 Nov 2024 | 50,000 | 50,000 (0%) | 0% | 43.8 | 2,188,500 | Class A Common Stock | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 06 Nov 2024 | 60,000 | 0 (0%) | 0% | 80.0 | 4,801,200 | Class A Common Stock | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 06 Nov 2024 | 30,000 | 60,000 (0%) | 0% | 43.8 | 1,313,100 | Class A Common Stock | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 06 Nov 2024 | 30,000 | 30,000 (0%) | 0% | 26.3 | 788,100 | Class A Common Stock | |
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 06 Nov 2024 | 30,000 | 50,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 06 Nov 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel Scavilla T. | Director, President, CEO | 26 Jan 2024 | 140,000 | 140,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 10 Oct 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 26 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel T. Scavilla | Director, President, CEO | 21 Apr 2022 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | ||
| Globus Medical Inc (Class A) | Daniel T. Scavilla | EVP, Chief Commercial Officer | 27 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy Class A Common Stock) |